Focus Taiwan App
Download

Taiwan-made enterovirus vaccine clears trial, could hit market soon

04/11/2021 08:28 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, April 11 (CNA) Taiwan-based Medigen Vaccine Biologics Corp. (MVC) on Sunday announced positive trial results for its enterovirus 71 (EV71) virus vaccine and expressed hope the vaccine could hit the market in Taiwan next year.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.40